Core Viewpoint - Rosen Law Firm is reminding investors who purchased Neogen Corporation common stock between January 5, 2023, and June 3, 2025, about the September 16, 2025, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Neogen common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court by September 16, 2025, to serve as lead plaintiff, representing other class members [3]. - Until a class is certified, investors are not represented by counsel unless they retain one, and they can choose to remain absent from the class [7]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been ranked No. 1 for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling significant cases [4]. Group 3: Case Background - The lawsuit alleges that Neogen's defendants made false and misleading statements during the class period, leading investors to believe that the integration process was progressing well, contrary to the reality [5]. - Initially, defendants claimed that the integration was "off to a great start" and that Neogen was experiencing solid core growth and profitability, which later proved to be misleading [5]. - The lawsuit claims that when the true situation was revealed, investors suffered damages due to the misrepresentation of the integration process [5].
NEOG DEADLINE: NEOG Investors Have Opportunity to Lead Neogen Corporation Securities Fraud Lawsuit